Mechanism of stroke in patients taking aspirin

M I Chimowitz1, A J Furlan, S Nayak

  • 1Department of Neurology, Cleveland Clinic Foundation, OH 44195.

Neurology
|November 1, 1990
PubMed

Insights

This study found that stroke in aspirin users has diverse causes and often leads to severe disability. Patients with carotid disease on aspirin frequently have high-grade stenosis, and strokes of unknown cause may recur.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Aspirin is a common antiplatelet medication used for stroke prevention.
  • Understanding stroke mechanisms in patients on aspirin is crucial for effective treatment and secondary prevention.
  • Cerebral infarction can occur despite antiplatelet therapy, necessitating investigation into underlying causes.

Purpose of the Study:

  • To prospectively investigate the mechanisms and severity of cerebral infarction in patients undergoing aspirin therapy.
  • To identify specific etiological factors contributing to stroke in this patient cohort.
  • To assess the functional outcomes and recurrence patterns of stroke in aspirin-treated individuals.

Main Methods:

  • Prospective study of 47 patients experiencing cerebral infarction while on aspirin therapy over a 1-year period.
  • Classification of stroke mechanisms, including large-artery atherosclerosis, cardioembolism, and small-vessel occlusive disease.
  • Evaluation of carotid artery status, degree of stenosis, and history of previous strokes.

Main Results:

  • Stroke mechanisms were undetermined in 26% of patients.
  • Identified mechanisms included large-artery atherosclerosis (40%), cardioembolism (32%), and small-vessel disease (11%).
  • Among patients with carotid atherosclerosis, 82% had >90% stenosis or occlusion.
  • Moderate to severe disability occurred in 57% of patients post-stroke.
  • Patients with stroke of undetermined mechanism had a high rate (83%) of prior stroke, often also of undetermined cause.

Conclusions:

  • Stroke in aspirin users exhibits diverse etiologies and frequently results in significant disability.
  • High-grade carotid stenosis or occlusion is common in aspirin-treated patients with carotid disease and stroke.
  • Strokes of undetermined mechanism may have a higher recurrence rate in patients taking aspirin.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...